Published in Am J Clin Pathol on March 01, 1999
Antigen retrieval immunohistochemistry: review and future prospects in research and diagnosis over two decades. J Histochem Cytochem (2011) 2.70
Analysis of protein expression in cell microarrays: a tool for antibody-based proteomics. J Histochem Cytochem (2006) 1.45
Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours. Br J Cancer (2006) 1.29
The immune system and inflammation in breast cancer. Mol Cell Endocrinol (2013) 1.12
Analytic Response Curves of Clinical Breast Cancer IHC Tests. J Histochem Cytochem (2017) 0.78
Spheroid arrays for high-throughput single-cell analysis of spatial patterns and biomarker expression in 3D. Sci Rep (2017) 0.75
Technical variations in prostatic immunohistochemistry: need for standardisation and stringent quality assurance in PSA and PSAP immunostaining. J Clin Pathol (2004) 0.75
A standard tissue as a control for histochemical and immunohistochemical staining. Biotech Histochem (2016) 0.75
Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med (2000) 4.67
Rearrangement of the p53 gene in human osteogenic sarcomas. Proc Natl Acad Sci U S A (1987) 4.21
Intra-abdominal desmoplastic small round-cell tumor. Report of 19 cases of a distinctive type of high-grade polyphenotypic malignancy affecting young individuals. Am J Surg Pathol (1991) 3.97
Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo. Lancet (1986) 3.93
The multitumor (sausage) tissue block: novel method for immunohistochemical antibody testing. Lab Invest (1986) 3.87
Benign transport of breast epithelium into axillary lymph nodes after biopsy. Am J Clin Pathol (2000) 3.55
Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo. Cancer Res (2001) 3.18
Interpretation and quantification of immunostains. Am J Surg Pathol (2001) 2.82
Effect of formalin tissue fixation and processing on immunohistochemistry. Am J Surg Pathol (2000) 2.76
Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nat Med (1995) 2.74
Alterations of myc, myb, and rasHa proto-oncogenes in cancers are frequent and show clinical correlation. Science (1986) 2.33
DACRYO-CYSTO-RHINOSTOMY. Br J Ophthalmol (1946) 2.32
Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas. Histopathology (2000) 2.27
Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells. Cancer Res (2000) 2.24
p27/Kip1 mutation found in breast cancer. Cancer Res (1996) 1.94
Keratin gene expression in non-epithelial tissues. Detection with polymerase chain reaction. Am J Pathol (1993) 1.84
When and to what end do pathologists agree? J Natl Cancer Inst (1998) 1.76
The distribution of vimentin and keratin in epithelial and nonepithelial neoplasms. A comprehensive immunohistochemical study on formalin- and alcohol-fixed tumors. Am J Clin Pathol (1987) 1.75
Further evidence that "malignant angioendotheliomatosis" is an angiotropic large-cell lymphoma. N Engl J Med (1986) 1.73
The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia. Am J Clin Pathol (1991) 1.70
Association of multiple copies of the c-erbB-2 oncogene with spread of breast cancer. Cancer Res (1987) 1.70
Cross-reactivity between Thy-1 and a component of intermediate filaments demonstrated using a monoclonal antibody. Nature (1981) 1.68
Transforming growth factor-beta and breast cancer risk in women with mammary epithelial hyperplasia. J Natl Cancer Inst (1999) 1.67
Quality control in immunohistochemistry. Report of a workshop sponsored by the Biological Stain Commission. Am J Clin Pathol (1989) 1.65
Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol (1991) 1.65
Isolation of large numbers of fully viable human neutrophils: a preparative technique using percoll density gradient centrifugation. Exp Hematol (1982) 1.59
Immunopathologic and molecular studies as an aid to the diagnosis of malignant mesothelioma. Hum Pathol (1992) 1.58
Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders. Hum Pathol (1998) 1.50
Prostatic acid phosphatase in carcinoid tumors. Immunohistochemical and immunoblot studies. Am J Surg Pathol (1991) 1.50
Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients. Cancer (1994) 1.50
Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy. Am J Obstet Gynecol (1998) 1.48
The use of antikeratin antiserum as a diagnostic tool: thymoma versus lymphoma. Hum Pathol (1980) 1.48
Monocytoid B-cell lymphoma. Am J Surg Pathol (1989) 1.47
Lymphohistiocytoid mesothelioma. An often misdiagnosed variant of sarcomatoid malignant mesothelioma. Am J Clin Pathol (2000) 1.46
Spindle cell carcinoma: ultrastructural evidence of squamous origin and collagen production by the tumor cells. Cancer (1976) 1.46
Reactive spindle cell nodules of the breast after core biopsy or fine-needle aspiration. Am J Clin Pathol (2000) 1.45
Leu-M1 antigen in human neoplasms. An immunohistologic study of 400 cases. Am J Surg Pathol (1986) 1.44
The influence of protease digestion and duration of fixation on the immunostaining of keratins. A comparison of formalin and ethanol fixation. J Histochem Cytochem (1986) 1.43
Cellular proliferation and prognosis in breast cancer: statistical purity versus clinical utility. Hum Pathol (1994) 1.41
Mice transgenic for human carcinoembryonic antigen as a model for immunotherapy. Cancer Res (1998) 1.40
Does rapid microwave fixation improve immunohistochemistry? Mod Pathol (1990) 1.39
The effect of decalcification on in situ hybridization. Mod Pathol (1997) 1.39
Specificity of immunohistochemical expression of P-glycoprotein. Hum Pathol (1991) 1.38
Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen. Cancer Res (1988) 1.25
Quantitative immunohistochemical assay for hormonal receptors: technical aspects and biological significance. J Cell Biochem Suppl (1994) 1.22
Listeriosis complicating lymphoma. Report of four cases and interpretive review of pathogenetic factors. Am J Med (1967) 1.20
Angiotropic (intravascular) large cell lymphoma. A clinicopathologic study of seven cases with unique clinical presentations. Cancer (1990) 1.18
Angiosarcoma of the gastrointestinal tract. A report of three cases. Cancer (1988) 1.17
Cardiac mitochondrial DNA polymerase-gamma is inhibited competitively and noncompetitively by phosphorylated zidovudine. Circ Res (1994) 1.17
No elevation in long-term breast carcinoma risk for women with fibroadenomas that contain atypical hyperplasia. Cancer (2001) 1.17
Distinction of mesothelioma from adenocarcinoma. An immunohistochemical approach. Cancer (1985) 1.15
The immunohistochemical diagnostic panel for epithelial mesothelioma: a reevaluation after heat-induced epitope retrieval. Am J Surg Pathol (1997) 1.15
Diabetic mastopathy. A clinicopathologic review. Am J Clin Pathol (2000) 1.15
Metaplastic breast tumors with a dominant fibromatosis-like phenotype have a high risk of local recurrence. Cancer (1999) 1.15
Fluorescent protein tracing in multiple sclerosis brain tissue. Arch Neurol (1969) 1.14
Non-Hodgkin's lymphoma involving the breast. Am J Surg Pathol (1994) 1.13
Expression of p21 ras oncoproteins in human cancers. Cancer Res (1986) 1.13
Malignant vascular tumors of the serous membranes mimicking mesothelioma. A report of 14 cases. Am J Surg Pathol (1996) 1.12
Bladder augmentation in the prevention of cyclophosphamide-induced haemorrhagic cystitis in the rat model. Br J Urol (1996) 1.11
Massive proteinuria associated with vesico-ureteral reflux. Lancet (1969) 1.11
Electron microscopy in the diagnosis of malignant schwannoma. Cancer (1981) 1.09
Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice. Proc Natl Acad Sci U S A (2000) 1.08
Proto-oncogene abnormalities in human breast cancer: correlations with anatomic features and clinical course of disease. J Clin Oncol (1987) 1.07
Routinely available indicators of prognosis in breast cancer. Breast Cancer Res Treat (1998) 1.07
Expression of biliary glycoprotein (CD66a) in normal and malignant breast epithelial cells. Anticancer Res (1998) 1.07
Protooncogene abnormalities in colon cancers and adenomatous polyps. Gastroenterology (1987) 1.07
Specificity of proto-oncogene amplification in human malignant diseases. Mol Biol Med (1987) 1.07
Intracytoplasmic lumina in breast carcinoma: a helpful histopathologic feature. Arch Pathol (1975) 1.05
Pulmonary Kaposi's sarcoma. Premortem histologic diagnosis. Am J Surg Pathol (1986) 1.03
Malignant fibrous histiocytoma. An electron microscopic study. Cancer (1977) 1.03
Core biopsy of the breast with atypical ductal hyperplasia: a probabilistic approach to reporting. Am J Surg Pathol (2001) 1.02
Selective interferon-induced enhancement of tumor-associated antigens on a spectrum of freshly isolated human adenocarcinoma cells. J Natl Cancer Inst (1989) 1.02
Adenomatoid tumors: a light microscopic, histochemical, and ultrastructural study. Cancer (1974) 1.01
Mammalian DNA polymerases alpha, beta, gamma, delta, and epsilon incorporate fialuridine (FIAU) monophosphate into DNA and are inhibited competitively by FIAU Triphosphate. Biochemistry (1994) 1.01
Sclerosing cholangitis after continuous hepatic artery infusion of FUDR. Ann Surg (1985) 1.00
Immunohistochemical evaluation of pleural mesothelioma and pulmonary adenocarcinoma. A bi-institutional study of 47 cases. Am J Surg Pathol (1987) 1.00
Sclerosing mucoepidermoid thyroid carcinoma with eosinophilia. A distinctive low-grade malignancy arising from the metaplastic follicles of Hashimoto's thyroiditis. Am J Surg Pathol (1991) 0.98
HBME-1 immunostaining in thyroid fine-needle aspirations: a useful marker in the diagnosis of carcinoma. Mod Pathol (1997) 0.98
Medullary carcinoma of the breast. Identification of lymphocyte subpopulations and their significance. Mod Pathol (1993) 0.98
The kidney in experimental magnesium deprivation. a morphologic and biochemical study. Am J Pathol (1966) 0.97
Endothelial area as a prognostic indicator for invasive breast carcinoma. Cancer (1996) 0.97
Specific keratins as molecular markers for neoplasms with a stratified epithelial origin. Cancer Res (1984) 0.97
"Carcinoid" tumor of the breast. A variant of conventional breast cancer? Hum Pathol (1981) 0.97
Direct sequencing analysis of exon 1 of the c-K-ras gene shows a low frequency of mutations in human pancreatic adenocarcinomas. Oncogene (1989) 0.97
Abnormalities of protooncogenes in non-small cell lung cancer. Correlations with tumor type and clinical characteristics. Cancer (1987) 0.96
Advantage of dose fractionation in monoclonal antibody-targeted radioimmunotherapy. J Natl Cancer Inst (1990) 0.96
Expression of the antigenic determinant recognized by the monoclonal antibody 44-3A6 on select human adenocarcinomas and normal human tissues. Tumour Biol (1988) 0.96
So-called sclerosing hemangioma of the lung. Evidence for mesothelial origin. Am J Surg Pathol (1983) 0.95
Generation of fibroblast-like cells from cloned epithelial mammary cells in vitro: a possible new cell type. Proc Natl Acad Sci U S A (1981) 0.95
Prognostic significance of immunohistochemical analysis of cathepsin D in low-stage breast cancer. Cancer (1993) 0.95
Follicle center lymphoma and Warthin tumor involving the same anatomic site. Report of two cases and review of the literature. Am J Clin Pathol (2000) 0.94
Signet-ring cell melanoma. A rare morphologic variant of malignant melanoma. Am J Surg Pathol (1988) 0.94
A monoclonal antibody useful for the differential diagnosis between malignant lymphoma and nonhematopoietic neoplasms. Cancer (1983) 0.93
Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue. Cancer Res (1990) 0.93
Treatment of two patients with diffuse cutaneous leishmaniasis caused by Leishmania mexicana modifies the immunohistological profile but not the disease outcome. Trop Med Int Health (1999) 0.93
A high-risk lesion for invasive breast cancer, ductal carcinoma in situ, exhibits frequent overexpression of retinoid X receptor. Cancer Epidemiol Biomarkers Prev (1998) 0.93
Hemangiopericytoma: ultrastructural study of five cases. Cancer (1973) 0.93
Medullary carcinoma of the breast: interobserver variability in histopathologic diagnosis. Mod Pathol (1995) 0.92
The search for the optimal immunohistochemical panel for the diagnosis of malignant mesothelioma. Hum Pathol (1993) 0.92